Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study.
Ann Rheum Dis
; 81(10): 1445-1452, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35788496
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Antineoplastic Agents, Immunological
/
Immune System Diseases
/
Melanoma
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Ann Rheum Dis
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: